guidelines:
  1: Sokal_Index_for_CML.v1
test_cases:
- id: Test no input
  input:
    1: {}
  expected_output:
    1: {}
- id: Age missing (negative test)
  input:
    1:
      'gt0004|Spleen size ': 40,cm
      gt0007|Platelet count: 140,10*9/l
      gt0025|% myeloblasts: 100,%
  expected_output:
    1: {}
- id: Spleen size missing (negative test)
  input:
    1:
      gt0007|Platelet count: 140,10*9/l
      gt0025|% myeloblasts: 100,%
      gt0024|Age: 30,a
  expected_output:
    1: {}
- id: Myeloblasts missing (negative test)
  input:
    1:
      'gt0004|Spleen size ': 30,cm
      gt0007|Platelet count: 140,10*9/l
      gt0024|Age: 30,a
  expected_output:
    1: {}
- id: Platelet count missing (negative test)
  input:
    1:
      'gt0004|Spleen size ': 30,cm
      gt0025|% myeloblasts: 40,%
      gt0024|Age: 30,a
  expected_output:
    1: {}
- id: Test Risk Group Low
  input:
    1:
      'gt0004|Spleen size ': 1,cm
      gt0007|Platelet count: 150,10*9/l
      gt0025|% myeloblasts: 1,%
      gt0024|Age: 30,a
  expected_output:
    1:
      gt0013|2-year Survival: local::at0008|90%|
      gt0011|Risk Group: local::at0004|Low|
      gt0014|Median Survival: local::at0012|5 years|
      gt0020|Sokal score: 0.6,1
- id: Test Risk Group High
  input:
    1:
      'gt0004|Spleen size ': 5,cm
      gt0007|Platelet count: 150,10*9/l
      gt0025|% myeloblasts: 20,%
      gt0024|Age: 50,a
  expected_output:
    1:
      gt0013|2-year Survival: local::at0010|65%|
      gt0011|Risk Group: local::at0006|High|
      gt0014|Median Survival: local::at0014|2.5 years|
      gt0020|Sokal score: 4.4,1
- id: Test Risk Group Intermediate
  input:
    1:
      'gt0004|Spleen size ': 5,cm
      gt0007|Platelet count: 150,10*9/l
      gt0025|% myeloblasts: 9,%
      gt0024|Age: 20,a
  expected_output:
    1:
      gt0013|2-year Survival: local::at0009|65-90%|
      gt0011|Risk Group: local::at0005|Intermediate|
      gt0014|Median Survival: local::at0013|2.5-5 years|
      gt0020|Sokal score: 1.2,1
- id: Test Conversion Factor
  input:
    1:
      'gt0004|Spleen size ': 5,in
      gt0007|Platelet count: 150,10*9/l
      gt0025|% myeloblasts: 9,%
      gt0024|Age: 20,a
  expected_output:
    1:
      gt0013|2-year Survival: local::at0010|65%| 
      gt0011|Risk Group: local::at0006|High| 
      gt0014|Median Survival: local::at0014|2.5 years|
      gt0020|Sokal score: 1.5,1
